JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Get Free Report) saw strong trading volume on Tuesday . 3,063,712 shares changed hands during mid-day trading, an increase of 891% from the previous session’s volume of 309,237 shares.The stock last traded at $65.61 and had previously closed at $65.50.
JPMorgan International Research Enhanced Equity ETF Stock Performance
The firm’s 50-day moving average price is $63.95 and its two-hundred day moving average price is $63.10. The stock has a market cap of $6.56 billion, a price-to-earnings ratio of 16.01 and a beta of 0.84.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Orion Portfolio Solutions LLC acquired a new position in JPMorgan International Research Enhanced Equity ETF in the fourth quarter valued at $1,000,000. Jones Financial Companies Lllp acquired a new stake in JPMorgan International Research Enhanced Equity ETF during the 4th quarter valued at $25,000. Belpointe Asset Management LLC acquired a new position in shares of JPMorgan International Research Enhanced Equity ETF in the fourth quarter worth $1,235,000. Cetera Advisor Networks LLC increased its position in JPMorgan International Research Enhanced Equity ETF by 11.0% during the 4th quarter. Cetera Advisor Networks LLC now owns 163,023 shares of the company’s stock worth $9,527,000 after purchasing an additional 16,122 shares in the last quarter. Finally, Leo Wealth LLC purchased a new position in JPMorgan International Research Enhanced Equity ETF in the 4th quarter valued at about $783,000.
About JPMorgan International Research Enhanced Equity ETF
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
See Also
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- What is a Low P/E Ratio and What Does it Tell Investors?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Calculate Inflation Rate
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Pros And Cons Of Monthly Dividend Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
